Evidence map›Paper›PMID 35058513›Full record

ArticleScientific reports2022

Ultrasensitive detection of SARS-CoV-2 nucleocapsid protein using large gold nanoparticle-enhanced surface plasmon resonance.

Taka-Aki Yano, Taira Kajisa, Masayuki Ono, Yoshiya Miyasaka, Yuichi Hasegawa, Atsushi Saito, Kunihiro Otsuka, Ayuko Sakane, Takuya Sasaki, Koji Yasutomo and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Research Progress on Nanomaterials in SPR Sensors.Nanomaterials (Basel, Switzerland) · 2025
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. ACS physical chemistry Au · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Taka-Aki Yano *Institute of Post-LED Photonics, Tokushima University, 2-1 Minami-Josanjima, Tokushima, 770-8506, Japan. yano.takaaki@tokushima-u.ac.jp.
Taira Kajisa *Institute of Post-LED Photonics, Tokushima University, 2-1 Minami-Josanjima, Tokushima, 770-8506, Japan.
Masayuki OnoJVCKENWOOD Corporation, 58-7, Shinmei-cho, Yokosuka, Kanagawa, 239-8550, Japan.
Yoshiya Miyasaka *JVCKENWOOD Corporation, 58-7, Shinmei-cho, Yokosuka, Kanagawa, 239-8550, Japan.
Yuichi HasegawaJVCKENWOOD Corporation, 58-7, Shinmei-cho, Yokosuka, Kanagawa, 239-8550, Japan.
Atsushi SaitoJVCKENWOOD Corporation, 58-7, Shinmei-cho, Yokosuka, Kanagawa, 239-8550, Japan.
Kunihiro OtsukaInstitute of Post-LED Photonics, Tokushima University, 2-1 Minami-Josanjima, Tokushima, 770-8506, Japan.
Ayuko SakaneInstitute of Post-LED Photonics, Tokushima University, 2-1 Minami-Josanjima, Tokushima, 770-8506, Japan.
Takuya SasakiDepartment of Biochemistry, Graduate School of Medical Sciences, Tokushima University, 3-18-15 Kuramoto, Tokushima, 770-8503, Japan.
Koji YasutomoInstitute of Post-LED Photonics, Tokushima University, 2-1 Minami-Josanjima, Tokushima, 770-8506, Japan.
Rina HamajimaResearch Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Yuta KanaiResearch Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Takeshi KobayashiResearch Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Yoshiharu MatsuuraResearch Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Makoto ItonagaJVCKENWOOD Corporation, 58-7, Shinmei-cho, Yokosuka, Kanagawa, 239-8550, Japan.
Takeshi YasuiInstitute of Post-LED Photonics, Tokushima University, 2-1 Minami-Josanjima, Tokushima, 770-8506, Japan. yasui.takeshi@tokushima-u.ac.jp.
Tokushima University · JPJVC Kenwood (Japan) · JPOsaka University · JP

Funding

Japan Agency for Medical Research and Development 20he0822006j00JST Moonshot R&D JPMJMS2025
6 · The paper itself

Abstract

The COVID-19 pandemic has created urgent demand for rapid detection of the SARS-CoV-2 coronavirus. Herein, we report highly sensitive detection of SARS-CoV-2 nucleocapsid protein (N protein) using nanoparticle-enhanced surface plasmon resonance (SPR) techniques. A crucial plasmonic role in significantly enhancing the limit of detection (LOD) is revealed for exceptionally large gold nanoparticles (AuNPs) with diameters of hundreds of nm. SPR enhanced by these large nanoparticles lowered the LOD of SARS-CoV-2 N protein to 85 fM, resulting in the highest SPR detection sensitivity ever obtained for SARS-CoV-2 N protein.

Indexed as

Coronavirus Nucleocapsid ProteinsSurface Plasmon ResonanceGoldMetal NanoparticlesPhosphoproteinsSARS-CoV-2Coronavirus Nucleocapsid ProteinsGoldnucleocapsid phosphoprotein, SARS-CoV-2Phosphoproteins

Identifiers

PMID35058513
PMCPMC8776812
OpenAlexW4206055770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.